Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.86, read 2026-11-02
Ethical does not pass the values gate
Price80.52 USD
Fair value96.88
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-28Read Markup78.74+2.3% to today ✓Distribution gives way to Markup first Markup read since September
2026-10-02Read Distribution78.49+2.6% to today Markup gives way to Distribution after a 30% rise in 6 weeks
2026-08-18Read Markup60.20+33.8% to today ✓Distribution gives way to Markup after a 31% rise in 7 weeks
2026-07-02Read Distribution45.91+75.4% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Wix.com Ltd. holds its Markup at $80.52. The statistical read favours the sellers, held for 6 days.
As held on the ledger · 2026-11-04
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 6 days
Price at the screen
$80.52
Valuation
N/A trailing · 11.74 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.03
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
60.77%
Below 33%
Interest-bearing debt is 60.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
18.35%
Below 33%
Cash held in interest-bearing accounts and securities is 18.3% of assets, under the one-third limit.
Pass
Receivables
13.52%
Below 49%
Money owed to the company is 13.5% of assets, under the 49% limit.
Pass
Revenue purity
2.45%
Below 5%
Only 2.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Wix.com's business is in a permissible area, but its interest-bearing debt is about 61% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WIX's ethical verdict changes
Today WIX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited by BDS movement as an Israeli-headquartered website builder platform with major operations in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 17% discount to our $96.88 fair value, 14.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 16.9% discount to the base estimate.
Where our models see it going: fair-value estimate $96.88, with a range of $94.80 to $158.00, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Drag and drop sites look easy until margins turn
Anyone can knock together a basic website these days with a few clicks and a credit card. Wix sits at the centre of that convenience yet still posts a negative profit margin and carries an unknown competitive moat despite 14 percent revenue growth and a forward multiple of just 7 times.
The valuation gap to our fair value looks wide on paper and the ethical screen clears without issue, yet the opportunity rating stays at none. Thin profitability and limited visibility on durable advantages outweigh the headline cheapness, especially when 20 analysts already cluster around a higher consensus target.
Risk sits in execution and competition from bigger platforms that can subsidise similar tools. Currency and macro exposure from its Israeli base add further swings. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Israel and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
WIX trades on Nasdaq (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup$74.70-5.1%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-10-28Markup · changed$78.74+6.0%Entry 9
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-10-21Distribution$74.31-2.9%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-10-14Distribution$76.56-2.5%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-09-17Markup$82.58+37.2%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 37.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-08-18Markup · changed$60.20+31.1%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 31.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-07-18Distribution$45.91+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (20 analysts) rates it buy, with a mean price target of $87.
2026-07-03Distribution$45.91+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$45.91Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
